522 related articles for article (PubMed ID: 16179880)
1. New drug-eluting stents, optimizing technique, and the problem of drug-eluting stent restenosis.
Vaina S; Ong AT; Serruys PW
Minerva Cardioangiol; 2005 Oct; 53(5):341-60. PubMed ID: 16179880
[TBL] [Abstract][Full Text] [Related]
2. Drug-eluting stents.
García-García HM; Vaina S; Tsuchida K; Serruys PW
Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
[TBL] [Abstract][Full Text] [Related]
3. Drug-eluting stent: the emerging technique for the prevention of restenosis.
Sheiban I; Carrieri L; Catuzzo B; Destefanis P; Oliaro E; Moretti C; Trevi GP
Minerva Cardioangiol; 2002 Oct; 50(5):443-53. PubMed ID: 12384626
[TBL] [Abstract][Full Text] [Related]
4. Drug-eluting coronary stents: many meta-analyses, little benefit.
Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
[TBL] [Abstract][Full Text] [Related]
5. Drug-eluting stents: results, promises and problems.
van der Hoeven BL; Pires NM; Warda HM; Oemrawsingh PV; van Vlijmen BJ; Quax PH; Schalij MJ; van der Wall EE; Jukema JW
Int J Cardiol; 2005 Mar; 99(1):9-17. PubMed ID: 15721493
[TBL] [Abstract][Full Text] [Related]
6. Are impaired endothelial progenitor cells involved in the processes of late in-stent thrombosis and re-endothelialization of drug-eluting stents?
Zhao FH; Chen YD; Jin ZN; Lu SZ
Med Hypotheses; 2008; 70(3):512-4. PubMed ID: 17764856
[TBL] [Abstract][Full Text] [Related]
7. Comparison of sirolimus versus paclitaxel eluting stents for treatment of coronary in-stent restenosis.
Airoldi F; Briguori C; Iakovou I; Stankovic G; Biondi-Zoccai G; Carlino M; Chieffo A; Montorfano M; Cosgrave J; Michev I; Rogacka R; Sangiorgi GM; Colombo A
Am J Cardiol; 2006 Apr; 97(8):1182-7. PubMed ID: 16616023
[TBL] [Abstract][Full Text] [Related]
8. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.
Whan Lee C; Kim SH; Suh J; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
Catheter Cardiovasc Interv; 2008 Apr; 71(5):594-8. PubMed ID: 18311841
[TBL] [Abstract][Full Text] [Related]
9. Current status and future prospects of drug eluting stents for restenosis.
Patel MJ; Patel SS; Patel NS; Patel NM
Acta Pharm; 2012 Dec; 62(4):473-96. PubMed ID: 23333885
[TBL] [Abstract][Full Text] [Related]
10. In-stent restenosis.
Kim MS; Dean LS
Cardiovasc Ther; 2011 Jun; 29(3):190-8. PubMed ID: 20406239
[TBL] [Abstract][Full Text] [Related]
11. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.
Caixeta A; Leon MB; Lansky AJ; Nikolsky E; Aoki J; Moses JW; Schofer J; Morice MC; Schampaert E; Kirtane AJ; Popma JJ; Parise H; Fahy M; Mehran R
J Am Coll Cardiol; 2009 Sep; 54(10):894-902. PubMed ID: 19712798
[TBL] [Abstract][Full Text] [Related]
12. Zotarolimus (ABT-578) eluting stents.
Burke SE; Kuntz RE; Schwartz LB
Adv Drug Deliv Rev; 2006 Jun; 58(3):437-46. PubMed ID: 16581153
[TBL] [Abstract][Full Text] [Related]
13. [Late stent thrombosis with drug eluting stents: disturbing signals on the radar].
Hansen PR
Ugeskr Laeger; 2007 Apr; 169(17):1561-3. PubMed ID: 17484825
[TBL] [Abstract][Full Text] [Related]
14. The paclitaxel-eluting stent in percutaneous coronary intervention: Part II. Comparison with the sirolimus-eluting stent, economics, and unanswered questions.
Ray GM; Nawarskas JJ; Frishman WH
Cardiol Rev; 2006; 14(3):143-50. PubMed ID: 16628023
[TBL] [Abstract][Full Text] [Related]
15. [Indications of drug eluting stents].
Cattan S; Michaud P; Nallet O; Allouch P; Elmamoud R; Leyer F; Osman R
Ann Cardiol Angeiol (Paris); 2004 Nov; 53(6):335-8. PubMed ID: 15603176
[TBL] [Abstract][Full Text] [Related]
16. Early experiences and clinical implications of restenosis and drug-eluting stents: Part 2.
Chong PH; Cheng JW
Ann Pharmacother; 2004 May; 38(5):845-52. PubMed ID: 15039482
[TBL] [Abstract][Full Text] [Related]
17. Drug-eluting stent for the treatment of small coronary lesion: comparison between sirolimus- and paclitaxel-eluting stent.
Li JJ; Xu B; Yang YJ; Chen JL; Qiao SB; Ma WH; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
Chin Med J (Engl); 2007 Apr; 120(7):569-73. PubMed ID: 17442204
[TBL] [Abstract][Full Text] [Related]
18. A randomized comparison of sirolimus-eluting stent implantation with zotarolimus-eluting stent implantation for the treatment of total coronary occlusions: rationale and design of the PRImary Stenting of Occluded Native coronary arteries III (PRISON III) study.
Suttorp MJ; Laarman GJ;
Am Heart J; 2007 Sep; 154(3):432-5. PubMed ID: 17719285
[TBL] [Abstract][Full Text] [Related]
19. Incidence and predictors of recurrent restenosis following implantation of drug-eluting stents for in-stent restenosis.
Lee CW; Park CB; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
Catheter Cardiovasc Interv; 2007 Jan; 69(1):104-8. PubMed ID: 17139669
[TBL] [Abstract][Full Text] [Related]
20. Drug-eluting stents.
Chieffo A; Colombo A
Minerva Cardioangiol; 2002 Oct; 50(5):419-29. PubMed ID: 12384624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]